Veradermics: Wait For The Post-Lockup, But Buy Before The Roll-Up
Veradermics Inc MANE
$105.00
▲ +0.35%
(+$0.37)
🔥 High Short Interest
🗓️ Earnings Next Week
Open
$103.47
Prev Close
$104.63
Day Range
$101.74 – $107.64
52W Range
$32.00 – $131.24
Market Cap
$4.39B
Beta
-0.51
EPS (TTM)
$-3.19
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 2026-02-04 |
| Shares Out. | 41,780,000 |
| Website | veradermics.com/ ↗ |
| Phone | 18009279800 |
| Employees | 21 |
| Net Income | -$27.2M |
| Total Assets | $397.4M |
| Total Liabilities | $6.7M |
| Equity | $390.6M |
About Veradermics Inc
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.
Veradermics Inc is a publicly traded company under the ticker symbol MANE on the NEW YORK STOCK EXCHANGE, INC., operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
12 analysts (2026-07-01)